Citius Pharmaceuticals, Inc. — Director's Dealing 2021

Oct 13, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Citius Pharmaceuticals, Inc. (CTXR)
CIK: 0001506251
Period of Report: 2021-10-11

Reporting Person: Mazur Leonard L (Director, Executive Chairman, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-10-11	Option to Purchase Common Stock	$2.04	A	650000	Acquired	2031-10-11	Common Stock (650000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10255343	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Options to Purchase Common Stock	$3.45	2027-09-13	Common Stock (40000)	40000	Direct
Warrant to Purchase Common Stock	$4.125	2022-08-08	Common Stock (421400)	421400	Direct
Warrant to Purchase Common Stock	$4.125	2022-08-08	Common Stock (11000)	11000	Direct
Options to Purchase Common Stock	$6.75	2024-09-12	Common Stock (220000)	220000	Direct
Warrant to Purchase Common Stock	$4.63	2023-06-19	Common Stock (106553)	106553	Direct
Warrant to Purchase Common Stock	$2.86	2023-09-29	Common Stock (167504)	167504	Direct
Warrant to Purchase Common Stock	$1.15	2023-08-14	Common Stock (3137255)	3137255	Direct
Options to Purchase Common Stock	$1.62	2028-09-04	Common Stock (150000)	150000	Direct
Warrant to Purchase Common Stock	$1.42	2024-04-05	Common Stock (1165048)	1615048	Direct
Warrant to Purchase Common Stock	$0.77	2024-09-27	Common Stock (2234700)	2234700	Direct
Options to Purchase Common Stock	$0.67	2029-10-08	Common Stock (175000)	175000	Direct
Options to Purchase Common Stock	$1.01	2030-10-06	Common Stock (200000)	200000	Direct
Options to Purchase Common Stock	$2.00	2031-07-22	Common Stock (300000)	300000	Direct

Footnotes

F1: One-third of the shares of the Company's common stock underlying the grant vest on the first anniversary of the vesting commencement date, September 13, 2018. The remaining shares of the Company's common stock underlying the grant vest in equal monthly installments at the end of each month for two years following the initial vest, provided the Reporting Person continues to serve as a member of the Company's Board of Directors as of each such vesting date.

F2: The warrant is fully vested and exercisable immediately.

F3: The option vested as to 40% of the shares of the Company's common stock on September 12, 2014 and 15% of the shares on each of September 12, 2015, March 12 and September 12, 2016 and September 12, 2017.

F4: One-third of the shares of the Company's common stock underlying the grant vest on each of the one-year, two-year and three-year anniversary of the vesting commencement date, September 4, 2018, provided that the Reporting Person provides continuous services to the Company as of each such vesting date.

F5: The options were granted on October 8, 2019. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

F6: The options were granted on October 6, 2020. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

F7: The options were granted on July 22, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.

F8: The options were granted on October 11, 2021. The options will vest 1/3 on each of the one-year, two-year and three-year anniversary of the Vesting Commencement Date, provided that the Optionee provides Continuous Service to the Company as of each such vesting date.